In this article, we discuss the 5 stocks receiving a massive vote of approval from Wall Street analysts. If you want to see more such stocks on the list, go directly to 10 Stocks Receiving a Massive Vote of Approval From Wall Street Analysts.
05. The Southern Company (NYSE:SO)
Price Reaction after the Upgrade: +0.90 (+1.31%)
On September 13, The Southern Company (NYSE:SO), a significant utility company, received an upgrade from Bank of America, sparking notable interest in the financial community. The stock was upgraded from “Underperform” rating to “Neutral”. As of the data available at the close of the market on September 13, The Southern Company (NYSE:SO) stock was trading at $70.42, reflecting a positive gain of 1.3%. However, this upgrade’s true significance lies in the price target change. Previously, the price target was set at $67.00, but it has now been raised to $68.00. This shift from an “Underperform” rating to a “Neutral” recommendation by Bank of America suggests a shift in perception regarding The Southern Company (NYSE:SO) prospects. The upgrade signifies a more stable outlook for Southern, and the increase in the price target from $67.00 to $68.00 underscores this newfound confidence.
04. National Fuel Gas Company (NYSE:NFG)
Price Reaction after the Upgrade: +0.69 (+1.32%)
On September 13, Scotiabank made significant adjustments to its assessment of National Fuel Gas Company (NYSE:NFG), which operates in the energy sector. The financial institution has upgraded its rating on National Fuel Gas Company (NYSE:NFG) from “Sector Perform” to “Sector Outperform,” indicating a more optimistic outlook for the company within its industry. However, it’s important to note that alongside this positive shift in recommendation, Scotiabank has also revised its price target for National Fuel Gas Company (NYSE:NFG). Previously set at $70, the new price target now stands at $68. This change in outlook from National Fuel Gas Company (NYSE:NFG) carries weight within the financial sector, drawing attention from investors and market analysts. The upgrade to “Sector Outperform” reflects Scotiabank’s belief that National Fuel Gas Company (NYSE:NFG) can outperform its industry peers, signaling potential growth and value for investors. While still optimistic, the decision to lower the price target suggests that Scotiabank may have adjusted its near-term expectations for National Fuel Gas Company (NYSE:NFG) stock performance.
03. American Electric Power Company, Inc. (NASDAQ:AEP)
Price Reaction after the Upgrade: +1.51 (+1.94%)
On September 13, American Electric Power (AEP) received an upgrade from Ladenburg Thalmann/SH SH. Previously tagged as a “Sell,” the updated recommendation now stands at “Neutral.” As of the latest available data, American Electric Power Company, Inc. (NASDAQ:AEP) stock was trading at $80.07, reflecting a modest gain of 0.9%. This upgrade from Ladenburg Thalmann/SH SH indicates a shift in perception regarding American Electric Power Company, Inc. (NASDAQ:AEP) performance and outlook. Moving from a “Sell” recommendation to a “Neutral” one suggests a more balanced view of the company’s potential. While the stock price change is relatively moderate, the change in recommendation can carry substantial weight for investors, influencing their decisions and portfolio strategies. Investors should closely monitor American Electric Power Company, Inc. (NASDAQ:AEP) progress following this upgrade, as it may offer valuable insights into the company’s prospects and market sentiment. The shift from “Sell” to “Neutral” signifies evolving dynamics within the energy sector and emphasizes the importance of adaptability in investment strategies.
02. ImmunoGen, Inc. (NASDAQ:IMGN)
Price Reaction after the Upgrade: +0.43 (+2.78%)
On September 13, ImmunoGen, Inc. (NASDAQ:IMGN) experienced a significant shift in its stock outlook thanks to an upgrade from JPMorgan Chase & Co., from “Neutral” to “Overweight”. As of the latest available data, ImmunoGen’s stock was trading at $15.86, showing a marginal dip of 0.1%. Yet, the real story here lies in the remarkable transformation of its price target. Previously set at a conservative $9.00, the revised price target now stands impressively at $22.00. JPMorgan Chase & Co.’s upgrade signifies a significant shift in the perception of ImmunoGen, Inc. (NASDAQ:IMGN) performance and potential. The transition from a “Neutral” recommendation to “Overweight” reflects a heightened sense of optimism regarding the company’s future prospects. While the change in stock price may seem subtle, the adjustment in the price target underlines JPMorgan’s strong belief in ImmunoGen’s growth trajectory. Investors closely monitor these developments as they offer valuable insights into the direction ImmunoGen, Inc. (NASDAQ:IMGN) is headed and the prevailing market sentiment. The upgrade from “Neutral” to “Overweight” underscores the ever-evolving dynamics within the biotechnology sector, reinforcing the importance of adaptability in investment strategies.
ClearBridge Multi Cap Growth Strategy made the following comment about ImmunoGen, Inc. (NASDAQ:IMGN) in its Q4 2022 investor letter:
“During the quarter we exited a position in ImmunoGen, Inc. (NASDAQ:IMGN), a biotechnology company developing antibody-drug conjugate therapies to treat cancer. ImmunoGen received FDA approval for Elahere for ovarian cancer, however it is a relatively modest opportunity and the company still faces a long road to reach meaningful profitability. The sale is also part of our effort to consolidate the portfolio in our highest conviction ideas.”
01. UMB Financial Corporation (NASDAQ:UMBF)
Price Reaction after the Upgrade: +1.98 (+3.20%)
UMB Financial Corporation (NASDAQ:UMBF) saw a 3.2% stock increase on September 13 after Piper Sandler upgraded it from Neutral to Overweight. The upgrade is due to the belief that several company-specific catalysts could boost the stock’s performance despite recent struggles. According to analyst Nathan Race, UMB Financial Corporation (NASDAQ:UMBF) has the potential for strong net interest income growth in the latter half of this year and 2024, driven by expanding loan yields, redeploying $300 million in quarterly securities cash flow run-off, and reduced deposit cost pressures. Additionally, robust fee income growth is expected to contribute significantly to overall revenue. While the stock’s technical indicators align with industry peers, its valuation is currently at a historical discount compared to its premium.
See also Conservative Stock Portfolio: 10 Best Stocks To Buy and What Are The Best Stocks To Buy Right Now?
